Regen BioPharma, Inc.
RGBP
$0.00
$0.00-50.00%
OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -715.80K | -1.73M | -1.27M | -972.80K | -935.60K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 44.40K | 48.30K | 52.00K | -24.20K | -12.50K |
| Total Other Non-Cash Items | 418.00K | 1.45M | 1.09M | 964.50K | 492.30K |
| Change in Net Operating Assets | -223.90K | -286.90K | -252.00K | -398.60K | -91.90K |
| Cash from Operations | -477.10K | -515.10K | -383.60K | -430.90K | -547.50K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 175.60K | 278.50K | 344.30K | 302.20K | 246.20K |
| Total Debt Repaid | -49.90K | -58.80K | -- | 40.50K | 61.50K |
| Issuance of Common Stock | 300.00K | 250.00K | 58.20K | 28.20K | 163.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 50.00K | 50.00K | 50.00K | -- | -- |
| Cash from Financing | 475.70K | 519.70K | 452.50K | 370.90K | 471.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | -1.50K | 4.40K | 68.80K | -60.10K | -76.40K |